Search - tctmd.com

Displaying 541 - 560 of 566

Sort: Relevancy | Date

News Daily News

Healthy Hearts Linked to Lower Risk of Frailty in Old Age

Leah Lawrence

May 11, 2016

News Daily News

Low BMI in and of Itself Portends Poor Survival After Acute MI

Caitlin E. Cox

April 21, 2016

News Daily News

激活大脑的压力中枢可能会刺激产生炎症和心血管事件

Todd Neale

March 28, 2016

News Daily News

La Activación del Centro de Estrés Cerebral Podría Provocar Inflamación y Episodios Cardiovasculares

Todd Neale

March 28, 2016

News Daily News

与心血管疾病相关的乳房 X 线检查结果经常被忽略和不报告

L.A. McKeown

March 25, 2016

News Daily News

Las Pistas de Enfermedad Cardiovascular que arrojan las Mamografías Suelen Pasarse por Alto

L.A. McKeown

March 25, 2016

News Daily News

备受争议的 LIGHT 试验现已发表，但未能证实 Contrave 的心血管风险

Michael O'Riordan

March 08, 2016

News Daily News

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

Michael O'Riordan

March 01, 2016

News Daily News

大环内酯类抗生素：队列研究显示其与室性心律失常的风险及死亡率增加无关

Michael O'Riordan

February 25, 2016

News Daily News

Antibióticos Macrólidos: No Acarrean un Mayor Riesgo de Arritmia Ventricular Ni de Mortalidad según un Estudio de Cohorte

Michael O'Riordan

February 25, 2016

News Daily News

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

Michael O'Riordan

December 27, 2015

News Daily News

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Michael O'Riordan

December 03, 2015

Presentation

Representation of Patients With Kidney Disease in Trials of CVD Interventions

Presenter: Ioannis Konstantinidis

December 02, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

Advertisement

Healthy Hearts Linked to Lower Risk of Frailty in Old Age

Low BMI in and of Itself Portends Poor Survival After Acute MI

激活大脑的压力中枢可能会刺激产生炎症和心血管事件

La Activación del Centro de Estrés Cerebral Podría Provocar Inflamación y Episodios Cardiovasculares

与心血管疾病相关的乳房 X 线检查结果经常被忽略和不报告

Las Pistas de Enfermedad Cardiovascular que arrojan las Mamografías Suelen Pasarse por Alto

备受争议的 LIGHT 试验现已发表，但未能证实 Contrave 的心血管风险

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

大环内酯类抗生素：队列研究显示其与室性心律失常的风险及死亡率增加无关

Antibióticos Macrólidos: No Acarrean un Mayor Riesgo de Arritmia Ventricular Ni de Mortalidad según un Estudio de Cohorte

BP Lowering Reduces Vascular Risk Regardless of Baseline BP and Disease History

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Representation of Patients With Kidney Disease in Trials of CVD Interventions

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content